首页 | 本学科首页   官方微博 | 高级检索  
检索        

痰热清注射液配合西药治疗胸外科术后肺部感染40例
引用本文:王瑞华,李颖,舒刚,梁伟.痰热清注射液配合西药治疗胸外科术后肺部感染40例[J].中国实验方剂学杂志,2012,18(15):279-281.
作者姓名:王瑞华  李颖  舒刚  梁伟
作者单位:贵州省六盘水市人民医院外三科,贵州六盘水,553001
摘    要:目的:观察痰热清注射液配合西药治疗胸外科术后肺部感染的临床疗效.方法:将符合病例人选标准的80例胸外科术后肺部感染患者随机分为观察组、对照组各40例.两组均常规行手术治疗,术后给予广谱抗生素积极预防、控制感染.同时以盐酸氨溴索注射液30 mL+生理盐水250 mL,gtt,1次/d.观察组在对照组治疗基础上给予痰热清注射液30 mL+生理盐水250 mL,gtt,1次/d.两组患者均以7d为1个疗程,治疗1个疗程后观察疗效.结果:痊愈率观察组77.50%,对照组62.50%,两组差异显著(P<0.05);总有效率观察95.00%,对照组82.50%,两组差异显著(P<0.05).咳痰、发热、啰音等消失时间,住院时间,胸片病灶消失时间观察组分别为(5.82±1.45),(3.68±1.15),(5.27±1.24),(4.68±1.08),(12.62±3.28)d,对照组分别为(7.68±1.72),(5.43±1.22),(7.36±1.55),(7.83 ±1.35),(15.15±3.18)d,观察组优于对照组(P<0.05).结论:痰热清注射液治疗胸外科术后肺部感染临床疗效显著,可缩短咳痰、发热、啰音等症状、体征消失时间,住院时间,胸片病灶消失时间.

关 键 词:肺部感染  胸外科  术后  痰热清注射液
收稿时间:2012/3/21 0:00:00

Tanreqing Injection in Treatment of Lung Infection after Thoracic Operation of 40 Cases
WANG Rui-hu,LI Ying,SHU Gang and LIANG Wei.Tanreqing Injection in Treatment of Lung Infection after Thoracic Operation of 40 Cases[J].China Journal of Experimental Traditional Medical Formulae,2012,18(15):279-281.
Authors:WANG Rui-hu  LI Ying  SHU Gang and LIANG Wei
Institution:The Third Department of Surgery, Liupanshui People's Hospital,Liupanshui 553001, China;The Third Department of Surgery, Liupanshui People's Hospital,Liupanshui 553001, China;The Third Department of Surgery, Liupanshui People's Hospital,Liupanshui 553001, China;The Third Department of Surgery, Liupanshui People's Hospital,Liupanshui 553001, China
Abstract:Objective: To observe the effect of Tanreqing injection in treatment of lung infection after thoracic operation. Method : Eiighty cases of lung infection after thoracic operation were randomly divided into the observation group, the control group with 40 cases in each group. The two groups underwent routine operation therapy, postoperative broad-spectrum antibiotic for prevention control of infection. At the same time with ambroxol hydrochloride injection 30 mL+250 mL saline, gtt, daily. Based on the treatment of control group the observation group was given Tanreqing injection 30 mL+250 mL saline, gtt daily. Two groups of patients were treateol for 7 days as a 1 course, the therapeutic effects were observed after 1 course of treatment. Result : The cure rate was 77.50% and 62.50% in the observation group and the control group, with significant difference (P<0.05); the total efficiency was 95% and 82.50% in the observation group and the control group with significant difference (P<0.05). Vanishing time of sputum, fever, rales, hospitalization time, chest lesions disappearance time in observation group were (5.82±1.45), (3.68±1.15), (5.27±1.24), (4.68±1.08), (12.62±3.28) d, and in the control group respectively (7.68±1.72), (5.43±1.22), (7.36±1.55), (7.83±1.35), (15.15±3.18) d, the observation group was beffer than in control group (P<0.05). Conclusion: The operation clinical curative effect of Tanreqing injection in treatment of lung infection after thoracic is remarkable. It can shorten the durations of sputum, fever, signs, rale disappearance, hospitalization and chest lesions disappearance.
Keywords:pulmonary infection  thoracic surgery  postoperative  Tanreqing injection
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号